Literature DB >> 25987622

Response to Switch from Intermittent Therapy to Daily Therapy for Refractory Nodular Bronchiectatic Mycobacterium avium Complex Lung Disease.

Won-Jung Koh1, Byeong-Ho Jeong2, Kyeongman Jeon2, Hye Yun Park2, Su-Young Kim2, Hee Jae Huh3, Chang-Seok Ki3, Nam Yong Lee3, Sung Jae Shin4, Charles L Daley5.   

Abstract

Intermittent three-times-weekly antibiotic therapy is recommended for the initial treatment of patients with noncavitary nodular bronchiectatic Mycobacterium avium complex lung disease. Although some experts recommend switching from intermittent to daily therapy for patients whose sputum has persistent positive cultures after intermittent therapy, the clinical efficacy of these modifications is unknown. Of 20 patients whose sputum had persistent positive cultures after 12 months of intermittent antibiotic therapy, specimens from 6 patients (30%) achieved a negative culture after a change to daily therapy.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25987622      PMCID： PMC4505207          DOI： 10.1128/AAC.00648-15

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  29 in total

1.  Mycobacterium avium-intracellulare pulmonary infection in HIV-negative patients without preexisting lung disease: diagnostic and management limitations.

Authors:  J H Huang; P N Kao; V Adi; S J Ruoss
Journal:  Chest       Date:  1999-04       Impact factor: 9.410

Review 2.  Nontuberculous mycobacterial (NTM) lung disease: the top ten essentials.

Authors:  Timothy R Aksamit; Julie V Philley; David E Griffith
Journal:  Respir Med       Date:  2013-09-25       Impact factor: 3.415

3.  Inhaled amikacin for treatment of refractory pulmonary nontuberculous mycobacterial disease.

Authors:  Kenneth N Olivier; Pamela A Shaw; Tanya S Glaser; Darshana Bhattacharyya; Michelle Fleshner; Carmen C Brewer; Christopher K Zalewski; Les R Folio; Jenifer R Siegelman; Shamira Shallom; In Kwon Park; Elizabeth P Sampaio; Adrian M Zelazny; Steven M Holland; D Rebecca Prevots
Journal:  Ann Am Thorac Soc       Date:  2014-01

4.  Geographical distribution and clinical relevance of non-tuberculous mycobacteria in Croatia.

Authors:  M Jankovic; M Samarzija; I Sabol; M Jakopovic; V Katalinic Jankovic; L Zmak; B Ticac; A Marusic; M Obrovac; J van Ingen
Journal:  Int J Tuberc Lung Dis       Date:  2013-06       Impact factor: 2.373

5.  Treatment of refractory Mycobacterium avium complex lung disease with a moxifloxacin-containing regimen.

Authors:  Won-Jung Koh; Goohyeon Hong; Su-Young Kim; Byeong-Ho Jeong; Hye Yun Park; Kyeongman Jeon; O Jung Kwon; Seung-Heon Lee; Chang Ki Kim; Sung Jae Shin
Journal:  Antimicrob Agents Chemother       Date:  2013-03-11       Impact factor: 5.191

6.  Repeat positive cultures in Mycobacterium intracellulare lung disease after macrolide therapy represent new infections in patients with nodular bronchiectasis.

Authors:  Richard J Wallace; Yansheng Zhang; Barbara A Brown-Elliott; Mitchell A Yakrus; Rebecca W Wilson; Linda Mann; Leslie Couch; William M Girard; David E Griffith
Journal:  J Infect Dis       Date:  2002-06-25       Impact factor: 5.226

7.  The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study.

Authors:  Wouter Hoefsloot; Jakko van Ingen; Claire Andrejak; Kristian Angeby; Rosine Bauriaud; Pascale Bemer; Natalie Beylis; Martin J Boeree; Juana Cacho; Violet Chihota; Erica Chimara; Gavin Churchyard; Raquel Cias; Rosa Daza; Charles L Daley; P N Richard Dekhuijzen; Diego Domingo; Francis Drobniewski; Jaime Esteban; Maryse Fauville-Dufaux; Dorte Bek Folkvardsen; Noel Gibbons; Enrique Gómez-Mampaso; Rosa Gonzalez; Harald Hoffmann; Po-Ren Hsueh; Alexander Indra; Tomasz Jagielski; Frances Jamieson; Mateja Jankovic; Eefje Jong; Joseph Keane; Wo-Jung Koh; Berit Lange; Sylvia Leao; Rita Macedo; Turid Mannsåker; Theodore K Marras; Jeannette Maugein; Heather J Milburn; Tamas Mlinkó; Nora Morcillo; Kozo Morimoto; Dimitrios Papaventsis; Elia Palenque; Mar Paez-Peña; Claudio Piersimoni; Monika Polanová; Nalin Rastogi; Elvira Richter; Maria Jesus Ruiz-Serrano; Anabela Silva; M Pedro da Silva; Hulya Simsek; Dick van Soolingen; Nora Szabó; Rachel Thomson; Teresa Tórtola Fernandez; Enrico Tortoli; Sarah E Totten; Greg Tyrrell; Tuula Vasankari; Miguel Villar; Renata Walkiewicz; Kevin L Winthrop; Dirk Wagner
Journal:  Eur Respir J       Date:  2013-04-18       Impact factor: 16.671

8.  Polyclonal Mycobacterium avium complex infections in patients with nodular bronchiectasis.

Authors:  R J Wallace; Y Zhang; B A Brown; D Dawson; D T Murphy; R Wilson; D E Griffith
Journal:  Am J Respir Crit Care Med       Date:  1998-10       Impact factor: 21.405

Review 9.  Update on the epidemiology of pulmonary nontuberculous mycobacterial infections.

Authors:  Brian A Kendall; Kevin L Winthrop
Journal:  Semin Respir Crit Care Med       Date:  2013-03-04       Impact factor: 3.119

10.  Identification and distribution of nontuberculous mycobacteria from 2005 to 2011 in cheonan, Korea.

Authors:  Jae Kyung Kim; Insoo Rheem
Journal:  Tuberc Respir Dis (Seoul)       Date:  2013-05-31
View more
  6 in total

1.  Peak Plasma Concentration of Azithromycin and Treatment Responses in Mycobacterium avium Complex Lung Disease.

Authors:  Byeong-Ho Jeong; Kyeongman Jeon; Hye Yun Park; Seong Mi Moon; Su-Young Kim; Soo-Youn Lee; Sung Jae Shin; Charles L Daley; Won-Jung Koh
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

2.  Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline.

Authors:  Charles L Daley; Jonathan M Iaccarino; Christoph Lange; Emmanuelle Cambau; Richard J Wallace; Claire Andrejak; Erik C Böttger; Jan Brozek; David E Griffith; Lorenzo Guglielmetti; Gwen A Huitt; Shandra L Knight; Philip Leitman; Theodore K Marras; Kenneth N Olivier; Miguel Santin; Jason E Stout; Enrico Tortoli; Jakko van Ingen; Dirk Wagner; Kevin L Winthrop
Journal:  Eur Respir J       Date:  2020-07-07       Impact factor: 16.671

3.  Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline.

Authors:  Charles L Daley; Jonathan M Iaccarino; Christoph Lange; Emmanuelle Cambau; Richard J Wallace; Claire Andrejak; Erik C Böttger; Jan Brozek; David E Griffith; Lorenzo Guglielmetti; Gwen A Huitt; Shandra L Knight; Philip Leitman; Theodore K Marras; Kenneth N Olivier; Miguel Santin; Jason E Stout; Enrico Tortoli; Jakko van Ingen; Dirk Wagner; Kevin L Winthrop
Journal:  Clin Infect Dis       Date:  2020-08-14       Impact factor: 9.079

Review 4.  Recent advances in nontuberculous mycobacterial lung infections.

Authors:  David Horne; Shawn Skerrett
Journal:  F1000Res       Date:  2019-10-01

Review 5.  Nontuberculous Mycobacteria Lung Disease (NTM-LD): Current Recommendations on Diagnosis, Treatment, and Patient Management.

Authors:  Kriti Pathak; Stephanie Hart; Leah Lande
Journal:  Int J Gen Med       Date:  2022-10-01

6.  Mycobacterium avium Complex: Addressing Gaps in Diagnosis and Management.

Authors:  Charles L Daley; Kevin L Winthrop
Journal:  J Infect Dis       Date:  2020-08-20       Impact factor: 5.226
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.